内容摘要：outside Gaza, though it portrays migration as “voluntary.” The Palestinians, along with nearly all of the international community, have rejected the idea.

outside Gaza, though it portrays migration as “voluntary.” The Palestinians, along with nearly all of the international community, have rejected the idea.

of receiving a pig kidney or heart.“It’s like a new beginning,” Looney, 53, told The Associated Press. Right away, “the energy I had was amazing. To have a working kidney — and to feel it — is unbelievable.”

Pig kidney recipient Towana Looney is visited by transplant surgeon Dr. Robert Montgomery at NYU Langone Health, in New York City. (AP Photo/Shelby Lum)Pig kidney recipient Towana Looney is visited by transplant surgeon Dr. Robert Montgomery at NYU Langone Health, in New York City. (AP Photo/Shelby Lum)Looney’s surgery marks an important step as scientists get ready for formal studies of xenotransplantation expected to begin next year, said Dr. Robert Montgomery of NYU Langone Health, who led the highly experimental procedure on Nov. 25.

On Tuesday, NYU announced that Looney is recuperating well. She was discharged from the hospital just 11 days after surgery although she was temporarily readmitted this week to adjust her medications. Doctors expect her to return home to Gadsden, Alabama, in three months. If the pig kidney were to fail, she could begin dialysis again.“To see hope restored to her and her family is extraordinary,” said Dr. Jayme Locke, Looney’s original surgeon who secured Food and Drug Administration permission for the transplant.

More than 100,000 people are on the U.S. transplant list, most who need a kidney. Thousands die waiting and many more who need a transplant never qualify. Now, searching for an alternate supply, scientists are genetically altering pigs so their organs are more humanlike.

Looney donated a kidney to her mother in 1999. Later pregnancy complications caused high blood pressure that damaged her remaining kidney, which eventually failed. It’s incredibly rare for living donors to develop kidney failure although those who do are given extra priority on the transplant list., an outspoken critic of the FDA’s handling of

Makary and other Trump administration officials already have taken unprecedented steps that raise uncertainty about next fall’s COVID-19 vaccinations, including delaying FDA scientists’— and then restricting its use to people at higher risk from the virus. They’ve also suggested

to match the latest circulating virus strains are new products requiring extra testing.The changes cross multiple health agencies.